logo
New leukaemia treatment hailed as ‘milestone' for patients

New leukaemia treatment hailed as ‘milestone' for patients

Yahooa day ago

Scientists have hailed a 'milestone' in leukaemia care for patients after a UK trial found a chemotherapy-free approach to treatment may lead to better outcomes for some patients.
The groundbreaking UK-wide trial could reshape the way the most common form of leukaemia in adults is treated.
Researchers from Leeds wanted to assess whether two targeted cancer drugs could perform better than standard chemotherapy among patients with chronic lymphocytic leukaemia (CLL).
They led the Flair trial, which took place at 96 cancer centres across the UK.
Some 786 people with previously untreated CLL were randomly assigned to receive standard chemotherapy; a single targeted drug, ibrutinib, or two targeted drugs taken together, ibrutinib and venetoclax, with treatment guided by personalised blood tests.
They found that after five years, 94% of patients who received ibrutinib plus venetoclax were alive with no disease progression.
This compares with 79% for those on ibrutinib alone and 58% for those on standard chemotherapy, according to the study, which has been published in the New England Journal of Medicine and presented to the European Haematology Association congress in Milan, Italy.
Meanwhile 66% of patients on the new combination had no detectable cancer in their bone marrow after two years, compared with none of the people who received ibrutinib alone and 48% on chemotherapy.
Ibrutinib is a type of drug known as a cancer growth blocker.
It works by stopping signals that cancer cells use to divide and grow.
And venetoclax blocks the functions of a protein found in CLL cells.
Experts said that the new treatment regime was also tolerated better than traditional treatments.
Dr Talha Munir, consultant haematologist at Leeds Teaching Hospitals NHS Trust, who led the study said: 'Flair trial is a milestone.
'We have shown that a chemotherapy-free approach can be not only more effective but also more tolerable for patients.
'By tailoring individualised treatment based on how well the cancer responds, we're moving into an era of truly personalised medicine.'
Catherine Whitfield, 63, from Farnley, West Yorkshire, was diagnosed with CLL in 2018 after she noticed symptoms including bleeding gums, constant illness and neck pain.
She signed up to the trial, which was co-ordinated by the Leeds Cancer Research UK Clinical Trials Unit at the University of Leeds and sponsored by the University of Leeds.
She said: 'After three years of treatment, I am still MRD negative – that means no cancer cells.'
'I lost my husband to cancer. I have seen how hard it could be.
'My first thought after my diagnosis was, I will never see my grandchildren being born and growing up.
'Now I have two grandchildren, Drew and Alaia, and they are a delight and highlight the joys of a healthy life'.
Ms Whitfield added: 'The way this trial was explained, it just made sense.
'Also, the thought of chemotherapy was scary to me. The trial felt right. And it was.'
Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, which funded the trial along with AbbVie, and Johnson and Johnson, said: 'The results of the Flair trial show that we can provide kinder, more targeted treatment for chronic lymphocytic leukaemia, which gives people with CLL more precious time with their loved ones.
'We're hopeful that the results of the Flair trial will power new treatment options for leukaemia and other blood cancers, thanks to the efforts of researchers at in Leeds and across the UK working together on this trial.'
Chronic lymphocytic leukaemia is the most common form of leukaemia in adults.
There are about 4,000 new CLL cases in the UK every year.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The best shoes for underpronation, according to podiatrists
The best shoes for underpronation, according to podiatrists

CNN

timean hour ago

  • CNN

The best shoes for underpronation, according to podiatrists

Shoes for underpronation quick picks Walking shoes for underpronation: Altra Lone Peak 9 Hybrid shoes for underpronation: Topo Athletic Traverse Flat shoes for underpronation: Vivobarefoot Geo Court III Whether you've recently visited a podiatrist or self-assessed your gait patterns, those with underpronation often benefit from the best shoes tailored uniquely to their feet. Not sure where on the spectrum you stand? 'Underpronation is when the foot lacks pronation and the foot doesn't roll inward enough during the gait cycle,' Rina Harris, a functional podiatrist based in London, England, and a virtual practitioner at Gait Happens, said. Thus, she explained underpronation is not a medical diagnosis but rather a general term used to describe inefficient foot movement patterns that don't typically allow for shock absorption and efficient weight distribution. While underpronation is not typically a podiatric emergency, keeping it unchecked may lead to other concerning issues, according to Paul Thompson, an Australia-based podiatrist at The Barefoot Movement and creator behind The Barefoot Podiatrist. 'This imbalance can lead to excessive strain on certain muscles, changes in movement patterns and compensatory gait adaptations.' For a step in the right direction, read on for the best podiatrist-recommended shoes for foot pain and discomfort that can assist with underpronation. Altra Women's Lone Peak 9 While Altra's Lone Peak series was designed uniquely for trail running, features like foamy zero-drop midsoles, a wide toe box to promote natural foot movement and StoneGuard inserts to protect feet from debris make them a stellar choice for getting your steps in at a comfortable, low-impact pace. Read our review Altra Men's Lone Peak 9 For walking shoes that'll take you far in your quest for a healthier gait pattern, look to these supportive Altra sneakers Harris dubs some of the absolute best out there for walking with underpronation. Altra Women's Olympus 6 Trail Running Shoes In these hiking-friendly shoes ideal for those experiencing underpronation, enjoy a roomy toe box, grippy outsoles for maximum stability on slick terrain and mesh uppers for breathability. Altra Men's Olympus 6 Trail Running Shoes Hit the hills with style and comfort in one of Thompson's top hiking shoes for underpronators. 'It's a max-cushioned option for those needing extra protection on rugged terrain,' he said. Altra Women's Escalante 4 If you've got a need for speed, Thompson suggests the latest Altra Escalante runners, now even lighter than their predecessors. 'They're lightweight and flexible with moderate cushioning for comfort on longer runs,' he said. Altra Men's Escalante 4 In these expert-approved men's running shoes suitable for those with underpronation, a socklike fit ensures they move with — as opposed to against — your natural foot shape and gait Athletic Women's Traverse If you'll be experimenting with a variety of terrains during your next cardio session, opt for these do-it-all athletic trainers. 'They're hybrid shoes that work well for both trail running and hiking,' Thompson said. Topo Athletic Men's Traverse A low heel-to-toe drop and durable yet flexible mesh uppers keep these trail shoes best suited to underpronators. Better yet, they're available in wide sizing (men's only). Vivobarefoot Women's Geo Court III Harris approves of Vivobarefoot's casual tennis shoes for those experiencing underpronation. She appreciates them for the way they support natural foot movements all while offering a wide toe box and flexible soles to help encourage pronation and improve overall foot function. Vivobarefoot Men's Geo Court III Wear them with your favorite dress pants or athleisure set — the sky's the limit with this practical and versatile pair of men's flats suitable for those with underpronation. Tennis-inspired and made of responsibly sourced leather, they make for a smart addition to your footwear Athletic Women's Fli-Lyte 5 These trainers are one of Thompson's top picks because they offer protection without feeling overly rigid or sacrificing the foot's natural movement pattern. 'They're a good all-around choice for runners who want a natural feel with a bit of extra protection,' he said. Topo Athletic Men's Fli-Lyte 5 Thanks to their forefoot rocker design, you can expect these protective men's running shoes to impart serious momentum into your next run, allowing you to hit high speeds in comfort and with efficiency. Topo Athletic Women's ST-5 'This is a minimalist-inspired option ... that offers a balance between natural movement and just enough cushioning to help absorb impact forces, which can be higher in underpronators,' Thompson said. Topo Athletic Men's ST-5 The minimalist shoe bandwagon is worth hopping on if you're looking to help address underpronation, but with a bit of extra responsive foam at the midsoles, these pared-down shoes feel even more accessible. Feelgrounds Original Knit No specific activity on the itinerary, just vibes? Feel the ground with Feelground's catchall minimalist shoes. They're a podiatrist's pick for their ability to accommodate a range of movement patterns, thanks in part to a generous toe box and supple soles. 'They're another minimalist shoe with no cushioning but flexible and well shaped for everyday wear,' Thompson Shoes Women's HFS II If hitting personal records is on your radar, take Thompson's lead and invest in his performance-oriented pick boasting an anatomic fit that's also free of a heel-to-toe drop. Xero Shoes Men's HFS II Thanks to their contoured fit, extra-grippy soles, wide toe box and light-as-air feel, the newest HFS road runners from Xero Shoes offer underpronators an efficient and comfortable stride. Vivobarefoot Women's Primus Flow It's no secret heavy layers of cushioning can offset your balance during strength training, leading to muscular overcompensations and potential injury. That's what makes these expert-approved barefoot-like training shoes a wise addition to your footwear lineup. Vivobarefoot Men's Primus Flow Train the smart way with Thompson's favorite training shoes for underpronation. 'They're breathable and versatile for casual wear or light training,' he Primus Trail FG III Harris recommends these barefoot-style trail walking shoes to help underpronators get out in the great outdoors. They're at once light and breathable, allowing you to go the extra mile in more ways than one. Some cushioning Thompson explained that an underpronating foot doesn't absorb shock as efficiently, so a small amount of cushioning can help alleviate some of that impact. 'However, if the rest of the kinetic chain is functioning well, we might even look at reducing cushioning and training the body to absorb impact more efficiently,' he said. 'It's about striking the right balance rather than relying on thick padding to compensate.' Minimal heel-to-toe drop 'Keeping the heel and forefoot at a similar level helps maintain ankle stability and prevents excessive lateral strain,' Thompson said. 'A raised heel shifts weight forward and can create further instability, especially at the ankle, increasing stress on the peroneals (the lateral muscles of the lower leg) and contributing to lateral ankle flare-ups.' Flexibility 'It's important to choose a shoe that allows natural foot movement and encourages pronation,' Harris said. 'A flexible, foot-shaped shoe that does not overly restrict motion can be beneficial. Many feet, even those that tend toward underpronation, are adaptable and can develop better movement patterns with proper foot training and footwear.' Thompson added that flexible soles can also promote better overall mechanics and control. Anatomically shaped To support proper gait patterns, Harris said your shoe should be anatomically designed to contour to the shape of your feet. '[It should be] foot-shaped, lightweight, flexible and designed to accommodate natural foot mechanics, similar to a minimalist or barefoot-style shoe,' she said. Wide toe box Toes need space to spread and stay engaged, according to Thompson, so your best bet is a wide toe box to accommodate these functions. 'The big toe, in particular, plays a big role in stability and propulsion, so we want to avoid anything that squishes or restricts it,' Thompson said. 'If the big toe is compressed and can't function properly, it can lead to inefficient propulsion, clawing of the lesser toes and increased lateral calf strain.' Bonus: A wide toe box can contribute to your overall comfort and prevent rubbing against foot deformities like bunions and hammer toe. The following FAQs have been answered by podiatrists Rina Harris and Paul Thompson. Aside from shoes, what else can help with underpronation? Aside from shoes, what else can help with underpronation? Apart from wearing appropriate footwear, Harris and Thompson said certain techniques can help restore natural foot function and promote pronation. Some example techniques include the following: Mobility exercises to stretch and mobilize the foot, ankle and lower leg. Balance training to strengthen and stabilize muscles that enhance foot adaptability. Barefoot training to enhance proprioception that offers the foot better movement control. Gait retraining, which encourages a more balanced and efficient stride to reduce compensatory patterns that contribute to underpronation. Sensory awareness drills that increase foot sensory feedback to help improve movement patterns. Foot-strengthening tools like toe spacers, balance beams and textured surfaces to help retrain the foot to move more naturally. Are underpronation and supination the same thing? Are underpronation and supination the same thing? Underpronation refers to the foot's inability to roll back in or pronate sufficiently, whereas supination refers to the foot rolling outward, or the arch lifting, according to Thompson, who added that both pronation and supination are necessary for healthy foot mechanics. Are stability shoes good for underpronation? Are stability shoes good for underpronation? Stability shoes are generally not recommended for underpronation because they limit pronation, according to Thompson. A foot that lacks pronation is typically more rigid, he explained, so adding a stiff and supportive shoe can further limit movement, potentially worsening the issue. Instead, he said individuals with underpronation should opt for shoes that allow for natural foot movements, which encourages pronation and shock absorption. A flexible, foot-shaped, zero-drop shoe with a wide toe box is more effective in promoting healthy movement patterns. We consulted the following experts to gain their insights on selecting the best shoes for underpronation. Rina Harris, a functional podiatrist based in London, England, and a virtual practitioner at Gait Happens Paul Thompson, an Australia-based podiatrist at The Barefoot Movement and creator behind The Barefoot Podiatrist CNN Underscored has a team of skilled writers and editors who have many years of experience testing, researching and recommending products, and they ensure each article is carefully edited and products are properly vetted. We talk to top experts when applicable to make certain we are testing each product accurately, recommending only the best products and considering the pros and cons of each item. Contributing editor and writer Marissa Miller has 15 years of experience testing and reporting on all things health and wellness while also serving as a certified personal trainer from the American Council on Exercise with a specialization in orthopedic exercise and senior fitness. For this article, she spoke with two podiatrists to gain their professional insights on how to choose the best shoes for underpronation.

Is the Truth Out There? Space Offers Hematology Insights
Is the Truth Out There? Space Offers Hematology Insights

Medscape

time4 hours ago

  • Medscape

Is the Truth Out There? Space Offers Hematology Insights

MILAN — An unexpected highlight here at this year's European Hematology Association (EHA) Congress came from beyond planet Earth. In a packed session titled Space Hematology , researchers and clinicians explored how frontier science intersects with practical medicine. Although the International Space Station and spaceflight might seem distant from the clinic, space offers a uniquely revealing experimental environment for hematology and for medicine more broadly. Microgravity, radiation exposure, circadian disruption, isolation, and other extreme conditions challenge human physiology in ways that are both scientifically illuminating and clinically relevant. Insights from experiments under these conditions can offer new perspectives for both treating and understanding the underlying mechanisms of hemoglobinopathies, coagulation disorders, or white blood cell dysfunction. Joseph Borg, PhD Perhaps most compelling, however, is this: Research conducted in space is no longer an expensive, distant aspiration — it is becoming a practical extension of the terrestrial laboratory. 'The technical and economic accessibility of space research has dramatically improved, and it will likely continue to do so, just as we saw with whole genome sequencing (WGS),' said Joseph Borg, PhD, professor and principal investigator at the University of Malta and investigator at NASA GeneLab, in an interview with Medscape Medical News . 'Regarding WGS, what once cost millions is now affordable for a large number of laboratories.' Space as a Lab: New Data From Far Away During the session, Borg presented findings showing that adult astronauts exhibit elevated levels of fetal hemoglobin (HbF), a molecule typically absent after infancy. His team, which has conducted annual experiments in space since 2021, analyzed peripheral blood using advanced omics technologies. Samples were collected pre-flight, during missions, and post-return. One study, published in Nature Communications , reported significant overexpression of gamma-globin genes ( HBG1 , HBG2 ), suggesting reactivation of fetal erythropoiesis during spaceflight. This pattern was consistent across different missions, including a polar orbit flight. Borg highlighted that the clinical relevance of these findings is that — in disorders like sickle cell disease or beta-thalassemia — increased HbF can reduce symptoms and improve quality of life. While gene-editing approaches like CRISPR-Cas9 aim to achieve this, they remain complex and costly. Inducing HbF through environmental triggers akin to those in space might offer a simpler alternative. Roopen Arya, MD Thrombosis risk in space has also transitioned from theoretical concern to real issue. 'Until 2019, there were no reported cases of venous thromboembolism (VTE) in astronauts,' noted Roopen Arya, MD, professor of thrombosis and hemostasis and clinical director for hematological medicine at King's College Hospital, UK. That changed with a case of jugular vein thrombosis described in JAMA Network Open . NASA's VTE working group subsequently developed in-flight diagnostic and treatment protocols. Another study on the secretome of civilians participating in a short-duration mission showed transient changes in coagulation and inflammatory markers. 'Very interesting data, even if we currently don't know what they mean,' Arya commented. Finally, white blood cell function is also altered in space. Judith-Irina Buchheim, MD, anesthesiologist at Ludwig-Maximilians-Universität (LMU) München, Germany, presented evidence that spaceflight can reduce NK cell cytotoxicity, affect T-cell activation, and trigger a state resembling inflammaging. 'If you're interested in aging research, space is probably the right choice for your experiments,' she said. 'You can see the effects prospectively very quickly, as early as 6 months.' Buchheim is also a member of the European Space Agency Medical Board and is leading its expert group for studying the effects of isolation, confinement, and extreme environments on the human body. Down to Earth: Why Space Medicine Matters Are these findings clinically applicable to Earth-based medicine or are they just curiosities from an elite group of astronauts and space agencies? According to the speakers, the implications are far-reaching. Astronauts offer ideal study subjects; they are healthy, highly monitored, and highly motivated individuals. Space acts as a physiological accelerator, revealing stress-response patterns and disease models that could take years to emerge on Earth. Insights into HbF reactivation could inspire pharmacologic mimicry. Coagulation changes may refine risk stratification for hospitalized or immobilized patients. And immune dysregulation observed in space could help clarify mechanisms of aging, vaccine response, and infection susceptibility. Space-based research also drives technological innovation. Devices miniaturized for orbit — blood analyzers, sequencing platforms — can be reengineered for bedside diagnostics in rural or low-resource settings, improving access to care. Why Space Hematology and Why Now? The inclusion of space hematology in the EHA Congress was deliberate. 'Most hematologists are not experts in space medicine, but this is already in the news and may become part of our clinical routine in 10-15 years,' Martin Dreyling, MD, professor of medicine and head of the lymphoma program at the Department of Medicine III, LMU Hospital Munich, told Medscape Medical News . He is the chair of the of the Scientific Program Committee for the EHA 2025 Congress, the group of experts in charge of selecting the topics to be presented at the event. Young investigators are especially drawn to the field, he added, attracted by its novelty, data richness, and interdisciplinary collaborations. Attendance by many early-career hematologists at the Milan session confirmed this growing interest. Martin Dreyling, MD With private companies offering logistical support, space is also now an optional arm in experimental design. 'It's about adding a new layer to your research and going deeper into biological mechanisms,' Borg explained to Medscape Medical News . He also emphasized the need for ethical oversight. Astronauts provide informed consent for biological sampling, and some opt to receive personal results. Nowadays, great attention to these issues is also needed for the 'new astronauts': that is, people who will be able to access commercial spaceflight and who are not as trained and risk-aware as traditional astronauts. It's tempting to ask whether data obtained from such a small and selected group of individuals are really significant for the population on Earth. Yet, despite small sample sizes, insights are accumulating. As more samples and subjects are sent into space and as repositories like the Space Omics and Medical Atlas grow, the potential for clinical translation increases. The long-term vision is a broader pool of space travelers, including commercial passengers, undergoing real-time health monitoring to yield diverse datasets. 'This is not a diversion from medicine's mission; it's an extension,' Borg told Medscape Medical News . 'Every doctor seeks better tools, new therapeutics, and deeper understanding. Space provides an extraordinary testbed that may reveal what Earth conceals.' From hemoglobin switching and thrombotic risk to immunosenescence and real-time drug testing, space hematology is no longer just a scientific curiosity. It's a fast-evolving frontier of translational research, he concluded.

Pulsar Fusion Confirms Expansion to U.S. with New Texas Office, Signs MOU with Thales Alenia Space, Unveils UK's Largest Space Testing Facility, and Releases New Mission Video to Titan
Pulsar Fusion Confirms Expansion to U.S. with New Texas Office, Signs MOU with Thales Alenia Space, Unveils UK's Largest Space Testing Facility, and Releases New Mission Video to Titan

Yahoo

time4 hours ago

  • Yahoo

Pulsar Fusion Confirms Expansion to U.S. with New Texas Office, Signs MOU with Thales Alenia Space, Unveils UK's Largest Space Testing Facility, and Releases New Mission Video to Titan

Sunbird Thruster Image Thales Alenia Space (TAS)-Image Pulsar Fusion & Thales Alenia Space (TAS)-Image LONDON and AUSTIN, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Pulsar Fusion, the UK-based fusion propulsion company behind the breakthrough Sunbird platform, today announced a series of major developments as it expands its global footprint, advances key partnerships, and showcases its vision for interplanetary travel. The company is opening a new U.S. office in Austin, Texas, positioning itself at the heart of the rapidly growing American space and innovation ecosystem. This strategic move supports Pulsar's increasing engagement with U.S.-based clients and investors. Pulsar UK has also signed a Memorandum of Understanding with Thales Alenia Space (TAS) in relation to Pulsar's 5kW MOONRANGER Hall-effect thrusters, which are being live test-fired. This signifies the latest indication of Pulsars broadening commercial appeal to Tier 1 aerospace primes. Meanwhile in Bletchley, England, Pulsar is preparing to pump down the first of its two newly built space-grade vacuum chambers, now officially the largest of their kind in the United Kingdom. These facilities will enable critical qualification and endurance testing for both Pulsar's Hall-effect thrusters and its next-generation Sunbird platform. As part of its public outreach and future mission planning, the company has also released its latest concept video, showcasing a Sunbird-powered mission to Saturn's moon Titan. The video illustrates how Pulsar's fusion systems could cut travel times dramatically, delivering critical payloads across the solar system faster and more efficiently than current propulsion methods allow. CEO Richard Dinan said: 'Nuclear fusion is the pinnacle of space propulsion technology. These reactors are uniquely suited for in-orbit use, and in many ways, it's more practical to use fusion for space propulsion than for energy on Earth. That said, we must pursue both and I believe we will ultimately succeed in both. The recent acceleration in AI capabilities is a true game-changer for fusion. These systems will help us manage ultra-hot plasmas with far greater precision, enabling reactors to become smaller, more intelligent, and vastly more practical. It's an incredibly exciting time to be building fusion systems' About Pulsar Fusion Ltd. Established in 2013 as Applied Fusion Systems, Pulsar Fusion develops hyper-fast space propulsion systems using nuclear fusion. Fusion offers the best alternative with sufficient exhaust speed and thrust to propel spacecraft beyond our solar system. In 2022 and 2023 Pulsar Fusion was awarded multiple funding rounds from the UK Space Agency to conduct research into nuclear electric propulsion and to expand their large HET development. Pulsar is creating an ecosystem of propulsion systems and services that advance the use of fusion as a near-limitless, clean energy source. For more information, visit Media Contact Danielle PerezFirecracker PRdanielle@ (888) 317-4687 ext. 705 A video accompanying this announcement is available athttps:// Photos accompanying this announcement are available athttps:// in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store